Please ensure Javascript is enabled for purposes of website accessibility

4th Circuit lets generic drug price-gouging ruling stand (access required)

Frosh weighs appeal to U.S. Supreme Court

The full 4th U.S. Circuit Court of Appeals on Tuesday refused to disturb a three-judge panel’s decision striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases of generic drugs, leaving the state with little options other than to seek review by the U.S. Supreme Court.

To purchase a reprint of this article, contact [email protected].